BAC
Bank of America Corporation
BAC has a slight edge over JXN overall, supported by stronger valuation and stronger modeled upside.
JXN
Jackson Financial Inc.
JXN's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
JXN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
JXN's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like JXN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over JXN in the historical PE scenario, which offers more potential upside but is not a forecast.
JXN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1x | $12.52 | -91% |
| Fair | 4x | $48.54 | -65% |
| Forward | 4.4x | $139 | — |
| Current | 11x | $139 | — |
| Expensive | 65x | $792 | +471% |
Historical ranges are pointers, not guarantees.
JXN's PE is in its expensive range at 11x. If earnings grow as analysts expect, today's price would be 4.4x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
JXN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for JXN, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over JXN on earnings, with more consistent year-over-year improvement.
JXN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $31.37 | +156% |
| Q3 2026 | $12.27 | +63% |
| Q2 2026 | $0.82 | +257% |
| Q1 2026 | -$6.00 | -555% |
| Q4 2025 | -$0.24 | -102% |
| Q3 2025 | $7.52 | +$19.21 |
| Q2 2025 | $0.23 | -99% |
| Q1 2025 | $1.32 | -97% |
| Q4 2024 | $11.74 | +9.1% |
JXN's earnings per share have fallen from their peak: $12.27 over the past year, against $78.10 in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over JXN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
JXN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +8.9% |
| Q1 2026 | $2.9B | -23% |
| Q4 2025 | $2B | +784% |
| Q3 2025 | $1.4B | -33% |
| Q4 2024 | $225M | -75% |
| Q3 2024 | $2.1B | -19% |
| Q2 2024 | $1.2B | +204% |
| Q3 2023 | $2.6B | -35% |
JXN's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 54% | +4.3 points |
| Q2 2026 | -309% | N/A |
| Q1 2026 | 75% | -7.3 points |
| Q4 2025 | 64% | +284 points |
| Q3 2025 | 50% | -15 points |
| Q1 2025 | 82% | N/A |
| Q4 2024 | -220% | -243 points |
| Q3 2024 | 65% | -11 points |
JXN has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
JXN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +3.4% |
| Q2 2026 | $1.8B | +58% |
| Q1 2026 | $1B | -34% |
| Q4 2025 | $1.6B | +6.3% |
| Q3 2025 | $1.4B | +0.4% |
| Q2 2025 | $1.2B | -21% |
| Q1 2025 | $1.6B | +12% |
| Q4 2024 | $1.5B | -6.7% |
JXN has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over JXN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
JXN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.6% | -1.8M shares |
| 1 year | -2.6% | -1.8M shares |
| 3 years | -17% | -14.4M shares |
| 5 years | -28% | -26M shares |
| Available history | -28% | -26M shares |
JXN has 68M diluted shares, down 2.6% from a year ago, with $839M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $233M |
| Q2 2026 | $227M |
| Q1 2026 | $227M |
| Q4 2025 | $152M |
| Q3 2025 | $157M |
| Q2 2025 | $158M |
| Q1 2025 | $202M |
| Q4 2024 | $99M |
JXN spent $839M buying back its own shares over the past year, up 36% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
JXN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | 0.4x | Very low |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | -0.2x | Net Cash |
| Q2 2022 | -0.2x | Net Cash |
JXN's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JXN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
JXN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.3 | Neutral |
| Stochastic | 53.7 | Neutral |
JXN's weekly RSI is 63 (neutral) and its Stochastic is 54 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
JXN PE vs Financial Services Sector
| Metric | JXN | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 70 | 65 | 5 pts above |
JXN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
JXN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $132.6 | 4.6% above |
| 20 week MA | $129.5 | 7.1% above |
| 50 week MA | $117.3 | 18% above |
| 100 week MA | $103.3 | 34% above |
| 200 week MA | $80.4 | 72% above |
JXN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
JXN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.8 | $39.9 | +39% |
| 2022 | $39.9 | $35.0 | -12% |
| 2023 | $35.0 | $51.2 | +46% |
| 2024 | $51.2 | $88.0 | +72% |
| 2025 | $88.0 | $108.2 | +23% |
| 2026 YTD | $108.2 | $138.6 | +28% |
JXN has the edge over BAC on returns for 2026, with the stronger performance.